शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans

This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →

NHBSENarayana Hrudayalaya Ltd· Healthcare ServicesHighNeutral
Announced Fri, 22 May, 2026 · 21:57 IST

Outcome of the Board meeting for the financial results for the quarter and year ended March 31 2026

Exceptional itemRevenue growth above 20%EBITDA margin compressionDebt to equity above the thresholdResults View source PDFExplain this filing

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.7%Reaction day
₹1848.30
prior close
₹1930.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.2%+3.5% vs market
Hospital peers, median of 23sector+0.3%+4.5% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Smallcap 250 and 4.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
+0.7
15m
+0.2
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.7+1.2+3.5+0.3+4.5
Next day
+2.7+1.4+1.3+0.1+2.6
2d
+4.1+2.0+2.2-0.4+4.5
3d
+5.0+1.3+3.7-0.5+5.5
4d
+3.2+0.5+2.7-1.0+4.2
5d
+4.3+1.0+3.3-1.4+5.6
1w
+5.8+1.7+4.2-0.6+6.5
15d
+0.8+3.5-2.8+0.6+0.2
1m
+5.6+5.5+0.1+1.1+4.5
2m
+11.1+6.3+4.8+4.7+6.4
3m
+2.5+9.4-6.9+4.1-1.6
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya reported FY26 standalone revenue from operations of ₹3,975 crore, up 10.7% YoY from ₹3,590 crore. EBITDA grew 24.8% to ₹1,016 crore with margins expanding from 22.7% to 25.6%. Net profit rose 16.7% to ₹503 crore vs ₹431 crore in FY25. Q4 standalone PAT was ₹202 crore on revenue of ₹1,044 crore. The board recommended a final dividend of ₹4.50 per share (450 paisa). Auditors Deloitte Haskins & Sells LLP issued an unmodified opinion on both standalone and consolidated results. An exceptional item of ₹45.28 crore was recognised in 9M FY26 due to increased gratuity and leave liability from new Labour Codes enactment. Two corporate restructuring proposals (MMRHL merger and NHIC demerger) are pending NCLT approval with no impact on current results. The company seeks shareholder approval to issue debt securities up to ₹1,500 crore.

Likely market impact

Strong operational performance with EBITDA margin expansion to 25.6% signals operational efficiency. PAT growth of 16.7% is healthy though below 25% threshold. The dividend and clean audit report are positive signals for shareholders.

By the numbersConsolidated · Q4 FY26 vs Q4 FY25
Q4 FY26Q4 FY25Change
Revenue₹2,594 Cr₹1,475 Cr+75.8%
Operating profit₹264.9 Cr₹234.5 Cr+13.0%
Profit after tax₹224.0 Cr₹197.3 Cr+13.5%
EBITDA margin19.7%23.7%−4.0 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.